Science and Technology News and Videos
weight loss injectables like Ozempic, a new finding from the company behind the blockbuster weight loss drugs is looking to expand its pediatric market., Novo Nordisk, the pharmaceutical firm behind Ozempic and Wegovy, boasts that one of its drugs can help lower the body mass index of children between the ages of 6 and 12.focuses on liraglutide, the active ingredient in the drug sold as Saxenda.
Conducted by an international group of medical researchers, this study concluded that kids who got the active liraglutide had an average BMI reduction of 5.8 percent, compared to 1.6 percent of children who got the placebo.is indeed a risk factor for health disorders both in youth and in adulthood, some medical experts are concerned that putting children that young on drugs as powerful and relatively new as GLP-1s could cause more harm than good.
"We do not know the long-term effectiveness and safety of these medicines in children," explained Roy Kim, a pediatric endocrinologist at the Cleveland Clinic, in an. "While the medicine was well tolerated, there are concerns about this category of medicines and possible pancreas problems, thyroid cancer risk and bone health over the lifetime.
Though both doctors suggested that the results of this small trial could be beneficial when considering treatment options for children with severe obesity, especially when trying to, it's still telling that even experts who are not wholesale against GLP-1s or their use on children have such concerns..
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Americans anxious about their health, concerned doctors will judge them: surveyDo Americans trust their doctors?
Read more »
Americans anxious about their health, concerned doctors will judge them: surveyDo Americans trust their doctors?
Read more »
Drugmakers say obesity medicine shortages are easing, but patients struggle to fill prescriptionsThe drug companies behind blockbuster weight loss and diabetes treatments have signaled that supply problems could soon be over, but many patients still have trouble getting the medicines.
Read more »
Drugmakers say obesity medicine shortages are easing, but patients struggle to fill prescriptionsThe drug companies behind blockbuster weight loss and diabetes treatments have signaled that supply problems could soon be over, but many patients still have trouble getting the medicines.
Read more »
Mississippi sues drugmakers and pharmacy benefit managers over opioidsMississippi is suing drug manufacturers and pharmacy benefit managers alleging that opioids were over-prescribed. Attorney General Lynn Fitch filed suit Thursday in state court. The suit names 13 companies and says they participated in “the worst man-made epidemic in modern medical history.
Read more »
Indonesia court fines drugmakers for toxic cough syrup that killed childrenThe court ordered the companies to pay 20 families who brought the suit compensation of 50 million rupiah ($3,217) for children who died and 60 million ($3,850) rupiah for children who were injured.
Read more »